In last trading session, FibroGen Inc (NASDAQ:FGEN) saw 0.78 million shares changing hands with its beta currently measuring 0.81. Company’s recent per share price level of $1.14 trading at $0.01 or 0.88% at ring of the bell on the day assigns it a market valuation of $113.40M. That closing price of FGEN’s stock is at a discount of -1607.89% from its 52-week high price of $19.47 and is indicating a premium of 71.05% from its 52-week low price of $0.33. Taking a look at company’s average trading volume volume of 1.98 million if we extend that period to 3-months.
FibroGen Inc (NASDAQ:FGEN) trade information
Upright in the green during last session for gaining 0.88%, in the last five days FGEN remained trading in the green while hitting it’s week-highest on Thursday, 05/02/24 when the stock touched $1.14 price level, adding 7.32% to its value on the day. FibroGen Inc’s shares saw a change of 28.62% in year-to-date performance and have moved 9.62% in past 5-day. FibroGen Inc (NASDAQ:FGEN) showed a performance of -27.85% in past 30-days.
FibroGen Inc (FGEN) estimates and forecasts
Statistics highlight that FibroGen Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 108.37% of value to its shares in past 6 months, showing an annual growth rate of 59.18% while that of industry is 11.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 5.20% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 36.67M for the same. And 2 analysts are in estimates of company making revenue of 37.67M in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -23.23% during past 5 years.
FGEN Dividends
FibroGen Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
